Watch Ticker

Castle Biosciences, Inc. Common Stock

Go to Castle Biosciences, Inc. Common Stock Website

$20.32

5.00 (32.64%)

Live

Previous Close

$20.35

Day Range

$18.68 - $21.3325

Previous Day Range

$14.59 - $15.41

Market Cap

$442.3 million USD

Day Vol.

2.0 million

Previous Day Vol.

884159

Currency

USD

Primary Exchange

Nasdaq

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes Decision...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Castle Biosciences Inc. - Castle Biosciences to Present at the Canaccord Genuity 45th Annual Growth Conference

Castle Biosciences announced its CEO Derek Maetzold was named a 2025 Most Admired CEO by the Houston Business Journal and received FDA Breakthrough Device designation for its DecisionDx-Melanoma test.

Related tickers: CSTL.

Read Full Article

Derek Maetzold - Castle Biosciences’ Founder, President and CEO Derek Maetzold Named a Most Admired CEO by the Houston Business Journal

Castle Biosciences' CEO Derek Maetzold was honored by the Houston Business Journal as a 2025 Most Admired CEO, recognizing his leadership in developing innovative diagnostic tests for various medical conditions.

Related tickers: CSTL.

Read Full Article

Trending Tickers

Please sign in to view